Cat.NO.:A159605 Purity:98%
Product Details of [ 1001-26-9 ]
| CAS No. : | 1001-26-9 |
| Formula : |
C7H12O3 |
| M.W : |
144.17
|
| SMILES Code : | O=C(OCC)/C=C/OCC |
| MDL No. : | MFCD00009863 |
| InChI Key : | ITQFPVUDTFABDH-AATRIKPKSA-N |
| Pubchem ID : | 5366269 |
Safety of [ 1001-26-9 ]
| GHS Pictogram: | ![]() |
| Signal Word: | Danger |
| Hazard Statements: | H315-H318-H335 |
| Precautionary Statements: | P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P310-P332+P313-P362-P403+P233-P405-P501 |
| Class: | 9 |
| UN#: | 3334 |
| Packing Group: | Ⅲ |
Computational Chemistry of [ 1001-26-9 ] Show Less
Physicochemical Properties
| Num. heavy atoms | 10 |
| Num. arom. heavy atoms | 0 |
| Fraction Csp3 | 0.57 |
| Num. rotatable bonds | 5 |
| Num. H-bond acceptors | 3.0 |
| Num. H-bond donors | 0.0 |
| Molar Refractivity | 37.66 |
| TPSA ?
Topological Polar Surface Area: Calculated from |
35.53 Ų |
Lipophilicity
| Log Po/w (iLOGP)?
iLOGP: in-house physics-based method implemented from |
2.44 |
| Log Po/w (XLOGP3)?
XLOGP3: Atomistic and knowledge-based method calculated by |
1.06 |
| Log Po/w (WLOGP)?
WLOGP: Atomistic method implemented from |
1.1 |
| Log Po/w (MLOGP)?
MLOGP: Topological method implemented from |
0.64 |
| Log Po/w (SILICOS-IT)?
SILICOS-IT: Hybrid fragmental/topological method calculated by |
0.95 |
| Consensus Log Po/w?
Consensus Log Po/w: Average of all five predictions |
1.24 |
Water Solubility
| Log S (ESOL):?
ESOL: Topological method implemented from |
-1.07 |
| Solubility | 12.2 mg/ml ; 0.0848 mol/l |
| Class?
Solubility class: Log S scale |
Very soluble |
| Log S (Ali)?
Ali: Topological method implemented from |
-1.4 |
| Solubility | 5.78 mg/ml ; 0.0401 mol/l |
| Class?
Solubility class: Log S scale |
Very soluble |
| Log S (SILICOS-IT)?
SILICOS-IT: Fragmental method calculated by |
-0.96 |
| Solubility | 15.8 mg/ml ; 0.11 mol/l |
| Class?
Solubility class: Log S scale |
Soluble |
Pharmacokinetics
| GI absorption?
Gatrointestinal absorption: according to the white of the BOILED-Egg |
High |
| BBB permeant?
BBB permeation: according to the yolk of the BOILED-Egg |
Yes |
| P-gp substrate?
P-glycoprotein substrate: SVM model built on 1033 molecules (training set) |
No |
| CYP1A2 inhibitor?
Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set) |
No |
| CYP2C19 inhibitor?
Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set) |
No |
| CYP2C9 inhibitor?
Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set) |
No |
| CYP2D6 inhibitor?
Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set) |
No |
| CYP3A4 inhibitor?
Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set) |
No |
| Log Kp (skin permeation)?
Skin permeation: QSPR model implemented from |
-6.43 cm/s |
Druglikeness
| Lipinski?
Lipinski (Pfizer) filter: implemented from |
0.0 |
| Ghose?
Ghose filter: implemented from |
None |
| Veber?
Veber (GSK) filter: implemented from |
0.0 |
| Egan?
Egan (Pharmacia) filter: implemented from |
0.0 |
| Muegge?
Muegge (Bayer) filter: implemented from |
1.0 |
| Bioavailability Score?
Abbott Bioavailability Score: Probability of F > 10% in rat |
0.56 |
Medicinal Chemistry
| PAINS?
Pan Assay Interference Structures: implemented from |
0.0 alert |
| Brenk?
Structural Alert: implemented from |
2.0 alert: heavy_metal |
| Leadlikeness?
Leadlikeness: implemented from |
No; 1 violation:MW<1.0 |
| Synthetic accessibility?
Synthetic accessibility score: from 1 (very easy) to 10 (very difficult) |
2.43 |
Application In Synthesis of [ 1001-26-9 ]
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
- Upstream synthesis route of [ 1001-26-9 ]
- Downstream synthetic route of [ 1001-26-9 ]



















Reviews
There are no reviews yet.